World UK to offer under-40s alternative to AstraZeneca shot
How the EU and AstraZeneca ended up in court, and what next
How the EU and AstraZeneca ended up in court, and what nextA first hearing in the case will be held at the Brussels Court of First Instance from 9 a.m. (0700 GMT) on Wednesday.
LONDON (AP) — People under 40 in Britain will not be given the Oxford-AstraZeneca coronavirus vaccine if another shot is available because of a link to extremely rare blood clots, the government said Friday. It said the change would not affect the goal of giving all U.K. adults at least one vaccine dose by July.
The Joint Committee on Vaccination and Immunization said people aged 30 to 39 without underlying health conditions should receive an alternative vaccine, “where available and only if this does not cause substantial delays in being vaccinated.” Last month it gave the same advice for people under 30.
Vaccination in Canada: A woman dies after receiving the Astrazeneca
VVID-19 vaccine This is the first time a person dies in Canada after receiving an injection against CVIV-19. It was 54 years old © Bruna Prado / AP / SIPA preparation of a dose of the Oxford-Astrazeneca vaccine against COVID-19. Risks - This is the first time a person dies in Canada after receiving an injection against CIVID-19. It was 54 years old This is a first in the Canada .
”Any vaccine offered early is preferable to a vaccine offered too late,” said Wei Shen Lim, who chairs the JCVI, an expert body that advises the government.
England’s deputy chief medical officer, Jonathan Van-Tam, said the government expects to be able to follow the new advice and still meet its target of giving everyone over 18 a vaccine jab by July 31.
“We have to maintain the pace and scale of the U.K. vaccination program,” Van-Tam said, adding that the AstraZeneca vaccine is safe and effective and “thousands are alive today” because they received it.
Britain has recorded more than 127,500 coronavirus deaths, the highest toll in Europe. But recent infections and deaths have plummeted thanks to extensive lockdowns and a rapid vaccination program. Two-thirds of U.K. adults have received at least vaccine jab and almost a third have had both doses.
EU pivots to Pfizer with world's biggest Covid-19 vaccine deal as it sues AstraZeneca
The European Union is pivoting to the Pfizer/BioNTech coronavirus shot with a record agreement to buy up to 1.8 billion doses, as court proceedings in its lawsuit against another major vaccine maker, AstraZeneca, began in Brussels on Wednesday. © JOHN THYS/AFP/POOL/AFP via Getty Images European Commission President Ursula von der Leyen addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.
A majority have had the AstraZeneca shot, though Britain is also using vaccines made by Moderna and Pfizer-BioNTech.
Several countries in Europe have chosen only to use the AstraZeneca vaccine on older people because of evidence there is a link to a type of very rare blood clot, accompanied by low blood platelet count.
British health officials say the risk from COVID-19 far exceeds any risk from the AstraZeneca vaccine for the vast majority of people, but the calculation is “more finely balanced” for younger groups, who tend not to suffer serious illness from coronavirus infections.
Up to April 28, Britain’s medicines regulator had received 242 reports of blood clots accompanied by low platelet count in people who had received the AstraZeneca vaccine, out of 28.5 million doses given. There were 49 deaths.
Most of the cases occurred after the first dose, and health officials said there were no concerns about people getting second AstraZeneca shots.
British regulator cites 41 more blood clot reports following AstraZeneca shots
British regulator cites 41 more blood clot reports following AstraZeneca shotsIn a weekly update on side effects from COVID-19 vaccines, the Medicines and Healthcare products Regulatory Agency (MHRA) said there were a total of 209 clots with low platelet counts following vaccination with AstraZeneca's shot, compared to a total of 168 reported last week.
The AstraZeneca vaccine, which is cheaper and easier to store than many others, is critical to global immunization campaigns and is a pillar of the U.N.-backed program known as COVAX that aims to get vaccines to some of the world’s poorest countries.
The success of Britain’s vaccination campaign is allowing the government to gradually lift lockdown measures. Later Friday, it's expecting to confirm that it will end a ban on overseas vacation travel, revealing a list of countries that U.K. residents will be able to visit starting later this month without having to quarantine upon return.
The “green list” of countries with low coronavirus infection rates is likely to include Israel, which has vaccinated most of its population, along with Malta and Gibraltar.
Foreign holidays are currently illegal under sweeping powers the British government has taken to restrict business and everyday life during the coronavirus pandemic.
The blanket travel ban is due to end on May 17. Pubs and restaurants in England can reopen indoor areas that day, and venues including theaters and cinemas can reopen to limited audiences. The other parts of the U.K. — Scotland, Wales and Northern Ireland — are following slightly different reopening timelines.
Follow more of AP’s pandemic coverage atand
AstraZeneca finally reaches vaccine shipping milestone to EU that was due in January .
AstraZeneca finally reaches vaccine shipping milestone to EU that was due in JanuaryBRUSSELS (Reuters) - AstraZeneca Plc has delivered 50 million doses of its COVID-19 vaccine to European Union countries, according to EU's latest supply data, a milestone it was originally due to hit in January.